Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: A 6-month double-blind comparison with propafenone and placebo

Background Existing drug therapies for paroxysmal supraventricular tachycardia (PSVT) have potentially serious adverse effects. Dofetilide, a pure class III antiarrhythmic agent, may offer an effective and safe alternative for treating PSVT. This study compared the efficacy and safety of dofetilide...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 2001-07, Vol.142 (1), p.93-98
Hauptverfasser:	Tendera, Michal, Wnuk-Wojnar, Anna Maria, Kulakowski, Piotr, Malolepszy, Józef, Kozlowski, J.W., Krzeminska-Pakula, M., Szechinski, Jacek, Droszcz, Waclaw, Kawecka-Jaszcz, Kalina, Swiatecka, Grazyna, Ruzyllo, Witold, Graff, Ole
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Aged Anti-Arrhythmia Agents - therapeutic use Antiarythmic agents Biological and medical sciences Cardiovascular system Double-Blind Method Female Humans Male Medical sciences Middle Aged Pharmacology. Drug treatments Phenethylamines - therapeutic use Propafenone - therapeutic use Proportional Hazards Models Sulfonamides - therapeutic use Survival Analysis Tachycardia, Supraventricular - prevention & control Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!